GlaxoSmithKline's (GSK) CEO Andrew Witty on Q3 2016 Results - Earnings Call Transcript

10/27/16

GlaxoSmithKline (NYSE:GSK)

Q3 2016 Earnings Conference Call

October 26, 2016 09:00 AM ET

Executives

Sir Andrew Witty - Chief Executive Officer

Simon Dingemans - Chief Financial Officer

Analysts

Graham Parry - Bank of America Merrill Lynch

James Gordon - JPMorgan

Andrew Baum - Citi

Kerry Holford - Exane BNP Paribas

Jo Walton - Credit Suisse

Tim Anderson - Bernstein

Keyur Parekh - Goldman Sachs

Steve Scala - Cowen

Richard Parkes - Deutsche Bank

Nicholas Guyon - Morgan Stanley

Jeff Holford - Jefferies

Seamus Fernandez - Leerink

READ FULL ARTICLE HERE

Recent Deals

Interested in advertising your deals? Contact Edwin Warfield.